牛磺酸联合微生态制剂治疗非酒精性脂肪性肝炎的疗效分析.doc

文档介绍：牛磺酸联合微生态制剂治疗非酒精性脂肪性肝炎的疗效分析
【摘要】目的评价牛磺酸联合微生态制剂治疗非酒精性脂肪性肝炎(NASH)的疗效。方法将120例NASH患者随机分为治疗组和对照组各60例,两组患者均禁酒、进行适量运动、改善饮食结构。治疗组在此基础上,+微生态制剂(双歧四联活菌片),每日三次,疗程为20周。结果治疗后,两组临床症状肝功能均有所改善,血糖、血脂、体重指数等较治疗前下降,P<。治疗组各项指标优于对照组,无明显不良反应。结论在饮食控制,加强运动基本治疗基础上,加用牛磺酸联合微生态制剂治疗,可有效改善NASH患者肝功能,血糖降低,耐受性较好。
【关键词】非酒精性脂肪性肝炎牛磺酸微生态制剂
【Abstract】Objective To evaluate the efficacy of bined with Micro-Ecological Agent on non-alcoholic fatty hepatitis(NASH). Method 120 NASHs were randomly divided into treatment group and the control group, with 60 patients in each group. Both groups were given routine treatment for prohibiting against alcoholic drinks, fitting exercise and improving diet structure. Treatment group were given Taurine() and Micro-Ecological Agent(siliankang,) three times a day by mouth in addition to routine treatment. Result After treatment, clinical symptoms and Liver Function were improved, and Blood Glucose
,Blood Lipid,Body Mass Index were decreased(P<). Indicators of treatment group were improved more significantly but no adverse reaction. Conclusion Taurine and Micro-Ecological Agent can improve the liver function and lower Blood Glucose of NASH on the basis of routine treatment,and have a good tolerance.
【Key Words】 Non-alcoholic Fatty Hepatitis Taurine Micro-Ecological Agent
非酒精性脂肪性肝炎(NASH)是以肝实质性细胞脂肪变性为病理特征,患者无过量饮酒史,且除外其他肝病的临床综合征。NASH患者中20~40%进展至肝纤维化或肝